Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13835)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chang ML. Metabolic alterations and hepatitis C: From bench to bedside. World J Gastroenterol 2016; 22(4): 1461-1476 [PMID: 26819514 DOI: 10.3748/wjg.v22.i4.1461] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i4/1461.htm |
| Number | Citing Articles |
| 1 |
A. Kabamba-Tshikongo, H. Manya-Mboni, C. Mwamba-Mulumba, N.B. Takaisi-Kikuni, A.T. Vandenbroucke, A.T. Pâques, G. Dessilly, B. Kabamba-Mukadi, A. Longanga-Otshudi. Hepatitis C virus among blood donors in Lubumbashi, DRC: Seroprevalence and molecular characterisation. Transfusion Clinique et Biologique 2023; 30(2): 272 doi: 10.1016/j.tracli.2023.02.007
|
| 2 |
Mark H. Kuniholm, Hua Liang, Kathryn Anastos, Deborah Gustafson, Seble Kassaye, Marek Nowicki, Beverly E. Sha, Emilia J. Pawlowski, Stephen J. Gange, Bradley E. Aouizerat, Tatiana Pushkarsky, Michael I. Bukrinsky, Vinayaka R. Prasad. Association of a 3′ untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women. AIDS 2017; 31(18): 2483 doi: 10.1097/QAD.0000000000001648
|
| 3 |
Thomas Tu, Sandra Bühler, Ralf Bartenschlager. Chronic viral hepatitis and its association with liver cancer. Biological Chemistry 2017; 398(8): 817 doi: 10.1515/hsz-2017-0118
|
| 4 |
Po-Chang Wang, Yi-Fang Wu, Ming-Shyan Lin, Chun-Liang Lin, Ming-Ling Chang, Shih-Tai Chang, Tzu-Chieh Weng, Mei-Yen Chen. The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional Analysis. International Journal of Environmental Research and Public Health 2022; 19(6): 3558 doi: 10.3390/ijerph19063558
|
| 5 |
Reem Y. Abdelkader, Mohamed A. Abdelrazek, Abdelfattah Attallah, Khaled Farid, Mohamed El-Far. High blood glucose levels are associated with fibrosis/cirrhosis progression in chronic hepatitis C. Journal of Immunoassay and Immunochemistry 2021; 42(6): 559 doi: 10.1080/15321819.2021.1911813
|
| 6 |
Dennis McDuffie, David Barr, Madeline Helm, Thomas Baumert, Ashutosh Agarwal, Emmanuel Thomas. Physiomimetic In Vitro Human Models for Viral Infection in the Liver. Seminars in Liver Disease 2023; 43(01): 031 doi: 10.1055/a-1981-5944
|
| 7 |
Shivani K. Thaker, James Ch’ng, Heather R. Christofk. Viral hijacking of cellular metabolism. BMC Biology 2019; 17(1) doi: 10.1186/s12915-019-0678-9
|
| 8 |
Yin-Yi Chu, Jur-Shan Cheng, Ting-Shu Wu, Chun-Wei Chen, Ming-Yu Chang, Hsin-Ping Ku, Rong-Nan Chien, Ming-Ling Chang. Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study. Journal of Clinical Medicine 2021; 10(11): 2395 doi: 10.3390/jcm10112395
|
| 9 |
Salwa M. Abo El-khair, Mona Arafa, Tarek Besheer, Ahmed M. El-Eraky, Ayman Z. Elsamanoudy. The Association of XRCC1 Gene Polymorphisms and Chronic Hepatitis C Induced Insulin Resistance in Egyptian Patients. Cells 2018; 7(11): 185 doi: 10.3390/cells7110185
|
| 10 |
Ming-Ling Chang, Jur-Shan Cheng, Ya-Hui Chuang, Li-Heng Pao, Ting-Shu Wu, Shiang-Chi Chen, Ming-Yu Chang, Rong-Nan Chien. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.823160
|
| 11 |
Y.-T. Cheng, J.-S. Cheng, C.-H. Lin, T.-H. Chen, K.-C. Lee, M.-L. Chang. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study. Clinical Microbiology and Infection 2020; 26(3): 366 doi: 10.1016/j.cmi.2019.06.018
|
| 12 |
Ming-Ling Chang, Tsung-Hsing Chen, Chen-Ming Hsu, Cheng-Hui Lin, Cheng-Yu Lin, Chia-Jung Kuo, Shu-Wei Huang, Chun-Wei Chen, Hao-Tsai Cheng, Chau-Ting Yeh, Cheng-Tang Chiu. The Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance. Nutrients 2017; 9(6): 570 doi: 10.3390/nu9060570
|
| 13 |
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of Hepatitis C Cure With Antivirals: Why Test and Treat?. Future Microbiology 2019; 14(5): 425 doi: 10.2217/fmb-2019-0041
|
| 14 |
Anca Trifan, Tudor Cuciureanu, Robert Nastasa, Ermina Stratina, Sebastian Zenovia, Cristina Maria Muzica, Laura Huiban, Ana-Maria Singeap, Stefan Chiriac, Catalin Sfarti, Camelia Cojocariu, Irina Girleanu, Horia Minea, Remus Stafie, Adrian Rotaru, Carol Stanciu. Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection. Life 2023; 13(2): 534 doi: 10.3390/life13020534
|
| 15 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
| 16 |
Alicia Oca�a‑Mondrag�n, Jos� Mata‑Mar�n, Mario Uriarte‑L�pez, Carolina Bekker‑M�ndez, Enrique Alcal�‑Mart�nez, Rosa Ribas‑Aparicio, Luis Uribe‑Nogu�z, Dulce Rodr�guez‑Galindo, Mar�a Mart�nez‑Rodr�guez. Effect of branched‑chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients. Biomedical Reports 2017; doi: 10.3892/br.2017.1012
|
| 17 |
Ming-Ling Chang, Jing-Hong Hu, Wei-Ting Chen, Ming-Shyan Lin, Chia-Jung Kuo, Shiang-Chi Chen, Rong-Nan Chien. Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels. Digestive Diseases and Sciences 2021; 66(7): 2407 doi: 10.1007/s10620-020-06507-9
|
| 18 |
John G Purdy, Micah A Luftig. Reprogramming of cellular metabolic pathways by human oncogenic viruses. Current Opinion in Virology 2019; 39: 60 doi: 10.1016/j.coviro.2019.11.002
|
| 19 |
Diego Casas-Deza, Silvia Espina, Ana Martínez-Sapiña, Raquel del Moral-Bergos, Maria Pilar Garcia-Sobreviela, Marta Lopez-Yus, Pilar Calmarza, Vanesa Bernal-Monterde, Jose M. Arbones-Mainar. Triglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals. Atherosclerosis 2023; 375: 59 doi: 10.1016/j.atherosclerosis.2023.05.003
|
| 20 |
J. Shah, E. Shao. Encyclopedia of Cardiovascular Research and Medicine. 2018; : 514 doi: 10.1016/B978-0-12-809657-4.11046-4
|
| 21 |
Heng Lee, Rong-Nan Chien, Li-Heng Pao, Chia-Jung Kuo, Po-Han Huang, Ming-Ling Chang. Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study. Cells 2021; 10(11): 2934 doi: 10.3390/cells10112934
|
| 22 |
Ramona Maria Draguţ, Emilia Rusu, Georgiana Enache, Horaţiu Popescu, Raluca Nan, Gabriela Radulian. Liver and Metabolic Diseases. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2016; 23(1): 105 doi: 10.1515/rjdnmd-2016-0013
|
| 23 |
Ming-Ling Chang, Jing-Hong Hu, Li-Heng Pao, Ming-Shyan Lin, Chia-Jung Kuo, Shiang-Chi Chen, Chun-Ming Fan, Ming-Yu Chang, Rong-Nan Chien. Critical role of triglycerides for adiponectin levels in hepatitis C: a joint study of human and HCV core transgenic mice. BMC Immunology 2021; 22(1) doi: 10.1186/s12865-021-00445-5
|
| 24 |
Ludovico Abenavoli, Luigi Boccuto. Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance. Virulence 2017; 8(7): 1069 doi: 10.1080/21505594.2017.1315498
|
| 25 |
Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, Tinny Endang Hernowati, Adeodatus Yuda Handaya, Hani Susianti, Moch. Bachtiar Budianto, Abdul Gofur, Eviana Norahmawati, Nia Lukita Ariani. Betatrophin expression in chronic hepatitis c patients: Does contribute to liver injury-linked metabolic syndrome and hepatocellular carcinoma development?. PROCEEDINGS OF THE 3RD INTERNATIONAL SEMINAR ON METALLURGY AND MATERIALS (ISMM2019): Exploring New Innovation in Metallurgy and Materials 2020; 2232: 030006 doi: 10.1063/5.0002469
|
| 26 |
Ashraf O. Abdelaziz, Hend I. Shousha, Ebada M. Said, Zeinab A. Soliman, Ahmed A. Shehata, Mohamed M. Nabil, Ahmed H. Abdelmaksoud, Tamer M. Elbaz, Fatma M. Abdelsalam. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1384 doi: 10.1097/MEG.0000000000001196
|
| 27 |
Ahmed Samir Allam, Mohamed Lotfy Abd Elmeged, Sameh Mohamed Ghaly, Osama Ashraf Ahmed, Gina Gamal Naguib, Ahmed Samir Abohalima. Impact of direct-acting antiviral therapy on metabolic profiles and adiponectin serum level in different categories of patients with chronic hepatitis C infection. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00194-z
|
| 28 |
Ming-Ling Chang, Chia-Jung Kuo, Li-Heng Pao, Chen-Ming Hsu, Cheng-Tang Chiu. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance. Virulence 2017; 8(7): 1255 doi: 10.1080/21505594.2017.1300734
|
| 29 |
Hend I. Shousha, Rasha A. Abdelaziz, Sherief M. Azab, Marwa Khairy, Shahira A. Afifi, Mai I. Mehrez, Mohamed A. Eshra, Ayman Y. Abdelrahim. Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C. Journal of Medical Virology 2018; 90(6): 1099 doi: 10.1002/jmv.25062
|
| 30 |
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk, Monika A. Jakubowska. When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis. The Journal of Physiology 2022; 600(11): 2579 doi: 10.1113/JP281135
|
| 31 |
Diego Casas-Deza, Ana Martínez-Sapiña, Silvia Espina, Beatriz Garcia-Rodriguez, Eva M. Fernandez-Bonilla, Alejandro Sanz-Paris, Yolanda Gonzalez-Irazabal, Vanesa Bernal-Monterde, Jose M. Arbones-Mainar. Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease. Journal of Clinical Medicine 2022; 11(14): 4049 doi: 10.3390/jcm11144049
|
| 32 |
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?. International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
|
| 33 |
Maoxia Liu, Jianlei Fu, Xuepeng Zhang, Qinyi Fu, Yi Ji, Siyuan Chen. The association between serum vitamin A concentrations and virus hepatitis among U.S. adults from the NHANES database: a cross-sectional study. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1387461
|
| 34 |
Jonathan G. Stine, Javelle A. Wynter, Blake Niccum, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C. Annals of Hepatology 2017; 16(2): 215 doi: 10.5604/16652681.1231581
|
| 35 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 36 |
Wesal Elgretli, Tianyan Chen, Nadine Kronfli, Giada Sebastiani. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines 2023; 11(2): 271 doi: 10.3390/biomedicines11020271
|
| 37 |
Thomas M. Ruli, Ethan D. Pollack, Atul Lodh, Charles D. Evers, Christopher A. Price, Mohamed Shoreibah. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers 2024; 16(11): 2042 doi: 10.3390/cancers16112042
|
| 38 |
Rita Moretti, Mauro Giuffrè, Nicola Merli, Paola Caruso, Stefano Di Bella, Claudio Tiribelli, Lory Saveria Crocè. Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders. Brain Sciences 2021; 11(12): 1569 doi: 10.3390/brainsci11121569
|
| 39 |
Tangui Barré, Marc Bourlière, Clémence Ramier, Fabrice Carrat, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Carole Cagnot, Céline Dorival, Fabien Zoulim, Jessica Zucman-Rossi, Jean-Charles Duclos-Vallée, Hélène Fontaine, Patrizia Carrieri. Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort). Journal of Clinical Medicine 2022; 11(20): 6135 doi: 10.3390/jcm11206135
|
| 40 |
Wei-Ting Chen, Mu-Shien Lee, Chia-Lin Chang, Cheng-Tang Chiu, Ming-Ling Chang. Retinol-binding protein-4 expression marks the short-term mortality of critically ill patients with underlying liver disease: Lipid, but not glucose, matters. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03096-y
|
| 41 |
Haiping Chen, Pei Du, Tianyao Yang, Xueyuan Xu, Tianyang Cui, Yuhang Dai. Hepatitis C virus infection is associated with high risk of breast cancer: a pooled analysis of 68,014 participants. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1274340
|
| 42 |
Natasha A. Trzaskalski, Branka Vulesevic, My-Anh Nguyen, Natasha Jeraj, Evgenia Fadzeyeva, Nadya M. Morrow, Cassandra A.A. Locatelli, Nicole Travis, Antonio A. Hanson, Julia R.C. Nunes, Conor O’Dwyer, Jelske N. van der Veen, Ilka Lorenzen-Schmidt, Rick Seymour, Serena M. Pulente, Andrew C. Clément, Angela M. Crawley, René L. Jacobs, Mary-Anne Doyle, Curtis L. Cooper, Kyoung-Han Kim, Morgan D. Fullerton, Erin E. Mulvihill. Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression. JCI Insight 2023; 8(2) doi: 10.1172/jci.insight.154314
|
| 43 |
Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț. The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-Analysis. Reports 2022; 5(4): 42 doi: 10.3390/reports5040042
|
| 44 |
Yingying Lin, Xinyu Cui, Na Zhu, Yanyan Li, Peng Wang, Xin Wang, Yunyun Yi, Xin Li. Association Between Retinol-Binding Protein 4 Levels and Hepatitis C Virus Infection: A Meta-Analysis. Diseases 2024; 12(11): 291 doi: 10.3390/diseases12110291
|
| 45 |
Ming-Ling Chang, Chia-Jung Kuo, Hsin-Chih Huang, Yin-Yi Chu, Cheng-Tang Chiu, Salvatore Petta. Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity. PLOS ONE 2016; 11(11): e0166712 doi: 10.1371/journal.pone.0166712
|
| 46 |
Chun-Wei Chen, Jur- Shan Cheng, Tsung-Hsing Chen, Chia-Jung Kuo, Hsin-Ping Ku, Rong-Nan Chien, Ming-Ling Chang. Different Metabolic Associations of Hepatitis C With Colon and Rectal Cancers: A 9-Year Nationwide Population-Based Cohort Study. Clinical Colorectal Cancer 2024; doi: 10.1016/j.clcc.2024.08.005
|
| 47 |
Megan H Powdrill, Geneviève F Desrochers, Ragunath Singaravelu, John Paul Pezacki. The role of microRNAs in metabolic interactions between viruses and their hosts. Current Opinion in Virology 2016; 19: 71 doi: 10.1016/j.coviro.2016.07.005
|
| 48 |
Jur-Shan Cheng, Yu-Sheng Lin, Jing-Hong Hu, Ming-Yu Chang, Hsin-Ping Ku, Rong-Nan Chien, Ming-Ling Chang. Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A Nationwide Population-Based Cohort Study. Journal of Clinical Medicine 2021; 10(4): 817 doi: 10.3390/jcm10040817
|
| 49 |
Tatsuo Kanda, Mitsuhiko Moriyama. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism. World Journal of Gastroenterology 2017; 23(31): 5645-5649 doi: 10.3748/wjg.v23.i31.5645
|
| 50 |
Ming-Ling Chang, Yu-sheng Lin, Li-Heng Pao, Hsin-Chih Huang, Cheng-Tang Chiu. Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance. Scientific Reports 2017; 7(1) doi: 10.1038/srep42503
|
| 51 |
Livia Melo Villar, Gabriela Cardoso Caldas, Leticia de Paula Scalioni, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Vanessa Alves Marques, Cristiane Alves Villela-Nogueira, Lia Laura Lewis-Ximenez, Elisabeth Lampe. High prevalence of insulin resistance among Brazilian chronic hepatitis C patients. Archives of Endocrinology and Metabolism 2017; 61(6): 628 doi: 10.1590/2359-3997000000315
|
| 52 |
Hyunsuk Yoo, Jeong Min Lee, Jeong Hee Yoon, Hyo-Jin Kang, Sang Min Lee, Hyun Kyung Yang, Joon Koo Han. T2* Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment?. Korean Journal of Radiology 2017; 18(4): 682 doi: 10.3348/kjr.2017.18.4.682
|
| 53 |
Kuan‐Chieh Lee, Ya‐Ting Cheng, Cheng‐Yu Lin, Chia‐Jung Kuo, Rong‐Nan Chien, Chau‐Ting Yeh, Ming‐Ling Chang. Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13‐year prospective cohort study. European Journal of Clinical Investigation 2020; 50(1) doi: 10.1111/eci.13189
|
| 54 |
Adrian Keogh, Sevil Şenkardeş, Jeffrey Idle, Ş. Küçükgüzel, Diren Beyoğlu. A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells. Metabolites 2017; 7(2): 23 doi: 10.3390/metabo7020023
|
| 55 |
Ming-Ling Chang, Kung-Hao Liang, Cheng-Lung Ku, Chia-Chi Lo, Ya-Ting Cheng, Chen-Ming Hsu, Chau-Ting Yeh, Cheng-Tang Chiu. Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms. Scientific Reports 2016; 6(1) doi: 10.1038/srep30799
|
| 56 |
Mario Frías, Antonio Rivero-Juárez, Isabel Machuca, Ángela Camacho, Antonio Rivero. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities. Expert Review of Precision Medicine and Drug Development 2020; 5(4): 253 doi: 10.1080/23808993.2020.1764346
|
| 57 |
Vanessa Gutierrez de ANDRADE, Fabio da Silva YAMASHIRO, Cassio Vieira OLIVEIRA, Leticia Lastória KUROZAWA, Alecsandro MOREIRA, Giovanni Faria SILVA. INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?. Arquivos de Gastroenterologia 2018; 55(2): 184 doi: 10.1590/s0004-2803.201800000-33
|
| 58 |
Hugo Christian Monroy-Ramirez, Marina Galicia-Moreno, Ana Sandoval-Rodriguez, Alejandra Meza-Rios, Arturo Santos, Juan Armendariz-Borunda. PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases. International Journal of Molecular Sciences 2021; 22(15): 8298 doi: 10.3390/ijms22158298
|
| 59 |
Ming-Ling Chang, Jur-Shan Cheng, Wei-Ting Chen, Chao-Wei Hsu, Kuan-Hsing Chen, Yung-Chang Chen, Rong-Nan Chien. Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia. Journal of Infection and Public Health 2024; 17(3): 486 doi: 10.1016/j.jiph.2024.01.010
|
| 60 |
Syed Shahariar Bappy, Md. Muzammal Haque Asim, Mohammad Mainul Ahasan, Asif Ahsan, Sorna Sultana, Roksana Khanam, Abu Zaffar Shibly, Yearul Kabir. Virus‐induced host cell metabolic alteration. Reviews in Medical Virology 2024; 34(1) doi: 10.1002/rmv.2505
|
| 61 |
Jing‑Hong Hu, Ming‑Ling Chang, Nai‑Jen Liu, Chu‑Ting Yeh, Tung‑Jung Huang. Effect of HCV treatment response on insulin resistance: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7995
|
| 62 |
Xu Li, Yang Gao, Hongqin Xu, Jie Hou, Pujun Gao. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09825-7
|
| 63 |
Jucéli Márcia Hendges Sparvoli, Antonio Cardoso Sparvoli, Afonso Alexandre Pereira, Ana Luisa Machado de Paula, Laís Garcia, Carla Vitola Gonçalves. Effects of hepatitis C virus genotypes and viral load on glucose and lipid metabolism after sustained virological response with direct-acting antivirals. Revista da Associação Médica Brasileira 2023; 69(5) doi: 10.1590/1806-9282.20221163
|
| 64 |
Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis. Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt – results from the GUARD study. Curr Med Res Opin 2017;33:797-801. Current Medical Research and Opinion 2017; 33(12): 2261 doi: 10.1080/03007995.2017.1333955
|
| 65 |
Tie-Hua Yang, Wen-Cong Gao, Xin Ma, Qian Liu, Pan-Pan Pang, Yong-Tang Zheng, Yinnong Jia, Chang-Bo Zheng. A Review on The Pathogenesis of Cardiovascular Disease of Flaviviridea Viruses Infection. Viruses 2024; 16(3): 365 doi: 10.3390/v16030365
|
| 66 |
Mark R Pedersen, Amit Patel, David Backstedt, Myunghan Choi, Anil B Seetharam. Genotype specific peripheral lipid profile changes with hepatitis C therapy. World Journal of Gastroenterology 2016; 22(46): 10226-10231 doi: 10.3748/wjg.v22.i46.10226
|
| 67 |
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, Sara Sohrabi Athar, Ali Salimi Jeda, Rumi Iqbal doewes, Abduladheem Turki Jalil, D. O. Bokov, Yasser Fakri Mustafa, Mina Noroozbeygi, Sajad Karampoor, Rasoul Mirzaei. Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism. Journal of Medical Virology 2022; 94(10): 4611 doi: 10.1002/jmv.27929
|
| 68 |
Ming-Ling Chang, Su-Wei Chang, Shiang-Chi Chen, Rong-Nan Chien, Chia-Lin Hsu, Ming-Yu Chang, Cathy S. J. Fann. Genetic Association of Hepatitis C-Related Mixed Cryoglobulinemia: A 10-Year Prospective Study of Asians Treated with Antivirals. Viruses 2021; 13(3): 464 doi: 10.3390/v13030464
|
| 69 |
Wei Chen, Xiao-ming Li, An-ling Li, Gui Yang, Han-ning Hu. Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression. Medical Science Monitor 2016; 22: 2347 doi: 10.12659/MSM.899591
|
| 70 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
|
| 71 |
Karina Gonzalez-Aldaco, Sonia Roman, Rafael Torres-Valadez, Claudia Ojeda-Granados, Luis A Torres-Reyes, Arturo Panduro. Hepatitis C virus clearance and less liver damage in patients with high cholesterol, low-density lipoprotein cholesterol and <i>APOE</i> ε<i>4</i> allele. World Journal of Gastroenterology 2019; 25(38): 5826-5837 doi: 10.3748/wjg.v25.i38.5826
|
| 72 |
JUR-SHAN Cheng, TSE-CHING CHEN, TAI-DI CHEN, HSIN-PING KU, SHU-WEI HUANG, TING-SHU WU, RONG-NAN CHIEN, MING-LING CHANG. Association between breast cancer and hepatitis C: A joint study of hospitalized patients and nationwide cohorts. Translational Research 2022; 245: 117 doi: 10.1016/j.trsl.2022.02.009
|
| 73 |
Li‐Ting Wang, Shen‐Nien Wang, Shyh‐Shin Chiou, Jhih‐Peng Tsai, Chee‐Yin Chai, Li‐Wen Tseng, Jin‐Ching Lee, Ming‐Hong Lin, Shau‐Ku Huang, Shih‐Hsien Hsu. HCV Core Protein–ISX Axis Promotes Chronic Liver Disease Progression via Metabolic Remodeling and Immune Suppression. Advanced Science 2023; 10(23) doi: 10.1002/advs.202300644
|
| 74 |
Jing-Hong Hu, Mei-Yen Chen, Chau-Ting Yeh, Huang-Shen Lin, Ming-Shyan Lin, Tung-Jung Huang, Ming-Ling Chang. Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients. Medicine 2016; 95(18): e3546 doi: 10.1097/MD.0000000000003546
|
| 75 |
Ming-Ling Chang, Sien-Sing Yang. Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology. Cells 2019; 8(11): 1423 doi: 10.3390/cells8111423
|
| 76 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals. JGH Open 2020; 4(4): 713 doi: 10.1002/jgh3.12324
|
| 77 |
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
|
| 78 |
Ming-Ling Chang, Yu-Sheng Lin, Ming-Yu Chang, Chia-Lin Hsu, Rong-Nan Chien, Cathy SJ Fann. Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study. Virulence 2021; 12(1): 270 doi: 10.1080/21505594.2020.1870080
|
| 79 |
Ming-Ling Chang, Zinger Yang, Sien-Sing Yang. Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression. International Journal of Molecular Sciences 2020; 21(21): 8308 doi: 10.3390/ijms21218308
|
| 80 |
Alessandro Gualerzi, Mattia Bellan, Carlo Smirne, Margherita Tran Minh, Cristina Rigamonti, Michela Emma Burlone, Ramona Bonometti, Sara Bianco, Azzurra Re, Serena Favretto, Giorgio Bellomo, Rosalba Minisini, Gian Piero Carnevale Schianca, Mario Pirisi, Emilio Russo. Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents. PLOS ONE 2018; 13(12): e0209216 doi: 10.1371/journal.pone.0209216
|
| 81 |
Gesche K. Gerresheim, Elke Roeb, Audrey M. Michel, Michael Niepmann. Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells 2019; 8(11): 1410 doi: 10.3390/cells8111410
|
| 82 |
Salvatore Petta. Hepatitis C virus and cardiovascular: A review. Journal of Advanced Research 2017; 8(2): 161 doi: 10.1016/j.jare.2016.06.001
|
| 83 |
Tom Domovitz, Samer Ayoub, Michal Werbner, Joel Alter, Lee Izhaki Tavor, Yfat Yahalom-Ronen, Evgeny Tikhonov, Tomer Meirson, Yaakov Maman, Nir Paran, Tomer Israely, Moshe Dessau, Meital Gal-Tanamy, Peter Pelka. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State. Microbiology Spectrum 2022; 10(6) doi: 10.1128/spectrum.01150-22
|
| 84 |
|
| 85 |
Chun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, Puo-Hsien Le, Hsin-Ping Ku, Ming-Ling Chang. The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819855732
|
| 86 |
Ming-Ling Chang, Mei-Ling Cheng, Su-Wei Chang, Hsiang-Yu Tang, Cheng-Tang Chiu, Chau-Ting Yeh, Ming-Shi Shiao. Recovery of pan-genotypic and genotype-specific amino acid alterations in chronic hepatitis C after viral clearance: transition at the crossroad of metabolism and immunity. Amino Acids 2017; 49(2): 291 doi: 10.1007/s00726-016-2360-7
|
| 87 |
Su-Wei Chang, Mei-Ling Cheng, Ming-Shi Shiao, Chau-Ting Yeh, Chao-Hung Wang, Chun-Ming Fan, Cheng-Tang Chiu, Ming-Ling Chang. Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidation. Journal of Clinical Lipidology 2018; 12(3): 756 doi: 10.1016/j.jacl.2018.02.011
|
| 88 |
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
|
| 89 |
Shaojian Li, Ruonan Liu, Qinling Pan, Genshu Wang, Daorou Cheng, Jie Yang, Hui Chen, Geyang Xu. De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus‐induced hepatocellular carcinoma. MedComm 2020; 1(2): 178 doi: 10.1002/mco2.15
|
| 90 |
Omar Ramos-Lopez, Sonia Roman, Erika Martinez-Lopez, Nora A Fierro, Karina Gonzalez-Aldaco, Alexis Jose-Abrego, Arturo Panduro. <i>CD36</i> genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection. World Journal of Hepatology 2016; 8(25): 1067-1074 doi: 10.4254/wjh.v8.i25.1067
|
| 91 |
Ming-Ling Chang, Wei-Ting Chen, Jing-Hong Hu, Shiang-Chi Chen, Po-Wen Gu, Rong-Nan Chien. Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter. Virulence 2020; 11(1): 1501 doi: 10.1080/21505594.2020.1838742
|
| 92 |
Simone Lanini, Paola Scognamiglio, Raffaella Pisapia, Claudia Minosse, Alessandro Agresta, Giuseppe Ippolito. Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy. International Journal of Antimicrobial Agents 2019; 53(5): 559 doi: 10.1016/j.ijantimicag.2018.11.024
|
| 93 |
Valeriy V. Tsvetkov, Ivan I. Tokin, Olesya E. Nikitina, Dmitry A. Lioznov. Disorders of lipid metabolism in the liver in patients with chronic viral hepatitis. HERALD of North-Western State Medical University named after I.I. Mechnikov 2021; 13(2): 27 doi: 10.17816/mechnikov71418
|
| 94 |
A. C. Cardoso, R. M. Perez, C. de Figueiredo‐Mendes, N. Carvalho Leite, H. S. Moraes‐Coelho, C. A. Villela‐Nogueira. Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP). Journal of Viral Hepatitis 2018; 25(11): 1244 doi: 10.1111/jvh.12930
|
| 95 |
Yu-Min Lin, Hung-Yu Sun, Wen-Tai Chiu, Hui-Chen Su, Yu-Chieh Chien, Heng-Ai Chang, Lee-Won Chong, Hung-Chuen Chang, Kung-Chia Young, Chyi-Huey Bai, Chiung-Wen Tsao. Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid Accumulation. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/3102414
|
| 96 |
Hussein A. AbdEl-maksoud, Mohamed G. Elharrif, Omnia Abd El-hamid, Saad M. Alsaab, Eman M. El-sorady. Monitoring of iron, lipid and liver profiles in Egyptian hepatitis C virus patients on sofosbuvir therapy. Journal of Infection and Public Health 2022; 15(3): 277 doi: 10.1016/j.jiph.2022.01.008
|
| 97 |
Mohamed El-Kassas, Abeer Awad. Metabolic aspects of hepatitis C virus. World Journal of Gastroenterology 2022; 28(22): 2429-2436 doi: 10.3748/wjg.v28.i22.2429
|
| 98 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|